Mamluk Roni 4
4 · Ayala Pharmaceuticals, Inc. · Filed Feb 24, 2021
Insider Transaction Report
Form 4
Mamluk Roni
DirectorCEO
Transactions
- Sale
Common Stock
2021-02-22$19.86/sh−15,200$301,813→ 163,271 total - Sale
Common Stock
2021-02-24$17.40/sh−10,800$187,919→ 145,345 total - Sale
Common Stock
2021-02-23$17.89/sh−7,126$127,483→ 156,145 total
Footnotes (1)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan.